Answers are grounded in this paper and cite their sources.
Retrospective cohort study evaluates antibiotic disk effectiveness in reducing infections in breast reconstruction, suggesting potential for enhanced surgical outcomes.
BACKGROUND: Infections involving tissue expanders and implants in breast reconstruction remain a persistent challenge for patients and reconstructive surgeons. When a prosthetic device shows signs of infection, it often results in unplanned readmission, additional operations, and, in many cases, reconstructive failure. Despite advancements in surgical techniques and perioperative care, infection rates continue to be unacceptably high. The difficulty lies in placing a prosthetic device within a devascularized post-mastectomy field, where bacterial contamination can readily lead to biofilm formation—rendering systemic antibiotics largely ineffective. These complications not only increase healthcare costs but also cause significant physical and emotional distress for patients. As a result, new strategies are needed to strengthen infection prevention in breast reconstruction. Antibiotic-releasing materials have been explored in various surgical specialties, including more recent interest with Polymethyl methacrylate (PMMA) for breast reconstruction. However, limited research exists on the use of antibiotic-impregnated, fully absorbable materials. This study introduces a novel application of antibiotic-impregnated calcium sulfate for the prevention and treatment of prosthetic infections in breast reconstruction. METHODS: A single-institution retrospective cohort study was performed on all patients who received an antibiotic eluting disk at the author’s institution between 2024 to 2025, excluding cases with insufficient postoperative follow up. A matching control cohort was selected from the years leading up to the adaptation of an absorbable antibiotic disk. Information was collected on patient factors, operative details, and the overall postoperative course. A combination of descriptive statistics, Fisher’s exact and Chi-square tests were obtained to evaluate the data set. RESULTS: A total of 187 breast pockets received an antibiotic disk and had at least 90 days of follow-up. Most disks were placed under a tissue expander or implant in either an immediate or delayed reconstruction (177, 94.7%), while a smaller subset was used as a salvage measure in patients with known periprosthetic infection (10, 5.3%). The incidence of infection was significantly lower in the antibiotic disk group compared with controls (4.8% vs. 14.2%, p<0.001). All 10 salvage cases, involving removal and replacement of the prosthesis with placement of a locally eluting antibiotic disk, were successful without recurrent infection. CONCLUSION: Absorbable antibiotic disks appear to be effective in reducing incidence of periprosthetic infections in breast reconstruction. This may also serve as a viable salvage treatment option in a small subset of patients who may otherwise abandon reconstruction. Further controlled trials are necessary, but the technique described may be a simple, reproducible, and cost-effective way to improve overall outcomes in breast reconstruction.
No takes yet. Share an insight, caveat, or question.
Denney et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: